Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content
The conversation 5

In countries such as the UK, US and Australia, strict laws and international conventions prohibiting the use of psychedelic drugs have made it almost impossible to research how these drugs work, and how they might be used to heal instead of harm – until recently. These barriers – together with cost, ethics committees, ideologically driven myths and stigma – have delayed research into a promising area of medicine. But things are changing for the better, as evidence and unmet need are at last being recognised.

Read the full article on The Conversation website, written by Rupert McShane (Consultant Psychiatrist, Department of Psychiatry) and Adam Winstock (University College London). 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.